PedAM

Pediatric Disease Annotations & Medicines

Disease	pancreatitis
Symptom	C0426768\|o sign
Sentences	7
PubMedID- 25448651	The pooled sensitivity and specificity of bmi as a predictor for the development of pancreatic necrosis were 0.90(95%ci = 0.56-0.99) and 0.70(95%ci = 0.58-0.79), respectively; with an overall area under curve value of 0.78.the pooled sensitivity and specificity of leptin levels as a predictor for development of pancreatic necrosis were 1(95%ci = 0.69-1) and 0.73(95%ci = 0.62-0.82),respectively; with an overall area under curve value of 0.82.nesfatin-1 and ghrelin levels showed no significant difference in patients with mild pancreatitis (6.97 +/- 0.84 ng/ml and 2.3(1.0-9.9);respectively) and severe pancreatitis (6.74 +/- 0.65 ng/ml and 2.0(1.9-9.9); respectively) (p = 0.1923 and 0.8531;respectively).
PubMedID- 22655061	Mpd in the head of pancreas was clearly visualized in 94.3% (509/540) of community group and 96.8% (30/31) of idiopathic pancreatitis group with no significant difference between the groups (fisher's exact test, p = 0.90).
PubMedID- 20006347	Conclusions: these observations demonstrate that ps-341 was able to significantly reduce the severity of acute pancreatitis induced by cerulein and lipopolysaccharide in mice.
PubMedID- 22529883	Lack or withdrawal of prior steroid usage was also significantly associated with pancreatitis (7/11 vs 4/17, p< 0.05) in our series.
PubMedID- 25266882	These observations demonstrate that s100a12 recombinant antibodies were able to significantly reduce the severity of acute pancreatitis induced by caerulein and lipopolysaccharide in mice.
PubMedID- 26417406	Both the us food and drug administration and the european medicines agency announced that there is no sign of increased risk of pancreatitis or pancreatic cancer with incretin-based therapies after a comprehensive review of the currently available data83.
PubMedID- 24583745	There was no significant difference of the frequency of pancreatitis between both groups.

Page: 1